Cargando…
Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome
Antiphospholipid syndrome (APS), characterized by artherial and/or venous thrombosis, pregnancy morbidity and “antiphospholipid” antibodies (aPLs), is more common in women than in men, with a female to male ratio of about 3.5:1. Only few studies have investigated the clinical differences between mal...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289158/ https://www.ncbi.nlm.nih.gov/pubmed/35860235 http://dx.doi.org/10.3389/fimmu.2022.932181 |
_version_ | 1784748601201655808 |
---|---|
author | Truglia, Simona Capozzi, Antonella Mancuso, Silvia Manganelli, Valeria Rapino, Luca Riitano, Gloria Recalchi, Serena Colafrancesco, Serena Ceccarelli, Fulvia Garofalo, Tina Alessandri, Cristiano Longo, Agostina Misasi, Roberta Conti, Fabrizio Sorice, Maurizio |
author_facet | Truglia, Simona Capozzi, Antonella Mancuso, Silvia Manganelli, Valeria Rapino, Luca Riitano, Gloria Recalchi, Serena Colafrancesco, Serena Ceccarelli, Fulvia Garofalo, Tina Alessandri, Cristiano Longo, Agostina Misasi, Roberta Conti, Fabrizio Sorice, Maurizio |
author_sort | Truglia, Simona |
collection | PubMed |
description | Antiphospholipid syndrome (APS), characterized by artherial and/or venous thrombosis, pregnancy morbidity and “antiphospholipid” antibodies (aPLs), is more common in women than in men, with a female to male ratio of about 3.5:1. Only few studies have investigated the clinical differences between male and female patients with APS. Therefore, this study was aimed to analyze the differences of clinical manifestations and laboratory tests, at diagnosis, between female and male APS patients and the clinical outcome. We enrolled 191 consecutive APS patients (125 with primary APS, PAPS, and 66 with secondary APS, SAPS) with a female predominant ratio of approximately 3:1 (142 vs 49). The prevalence of PAPS was higher in males than females (p<0.001). The analysis of aPL profile revealed that high IgM anti-cardiolipin (aCL) and high-medium IgG aCL titers were more frequent in males. In thrombotic APS peripheral arterial thrombosis was more common in male than female patients (p=0.049), as well as myocardial infarction (p=0.031). Multivariate analysis to correct for cardiovascular risk factors, high titer of aPLs and triple positivity for aPLs, revealed that the odds ratio for myocardial infarction in male was 3.77. Thus, APS may be considered as a disease in which serological (IgM titer) and clinical profiles are influenced by gender. |
format | Online Article Text |
id | pubmed-9289158 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92891582022-07-19 Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome Truglia, Simona Capozzi, Antonella Mancuso, Silvia Manganelli, Valeria Rapino, Luca Riitano, Gloria Recalchi, Serena Colafrancesco, Serena Ceccarelli, Fulvia Garofalo, Tina Alessandri, Cristiano Longo, Agostina Misasi, Roberta Conti, Fabrizio Sorice, Maurizio Front Immunol Immunology Antiphospholipid syndrome (APS), characterized by artherial and/or venous thrombosis, pregnancy morbidity and “antiphospholipid” antibodies (aPLs), is more common in women than in men, with a female to male ratio of about 3.5:1. Only few studies have investigated the clinical differences between male and female patients with APS. Therefore, this study was aimed to analyze the differences of clinical manifestations and laboratory tests, at diagnosis, between female and male APS patients and the clinical outcome. We enrolled 191 consecutive APS patients (125 with primary APS, PAPS, and 66 with secondary APS, SAPS) with a female predominant ratio of approximately 3:1 (142 vs 49). The prevalence of PAPS was higher in males than females (p<0.001). The analysis of aPL profile revealed that high IgM anti-cardiolipin (aCL) and high-medium IgG aCL titers were more frequent in males. In thrombotic APS peripheral arterial thrombosis was more common in male than female patients (p=0.049), as well as myocardial infarction (p=0.031). Multivariate analysis to correct for cardiovascular risk factors, high titer of aPLs and triple positivity for aPLs, revealed that the odds ratio for myocardial infarction in male was 3.77. Thus, APS may be considered as a disease in which serological (IgM titer) and clinical profiles are influenced by gender. Frontiers Media S.A. 2022-07-04 /pmc/articles/PMC9289158/ /pubmed/35860235 http://dx.doi.org/10.3389/fimmu.2022.932181 Text en Copyright © 2022 Truglia, Capozzi, Mancuso, Manganelli, Rapino, Riitano, Recalchi, Colafrancesco, Ceccarelli, Garofalo, Alessandri, Longo, Misasi, Conti and Sorice https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Truglia, Simona Capozzi, Antonella Mancuso, Silvia Manganelli, Valeria Rapino, Luca Riitano, Gloria Recalchi, Serena Colafrancesco, Serena Ceccarelli, Fulvia Garofalo, Tina Alessandri, Cristiano Longo, Agostina Misasi, Roberta Conti, Fabrizio Sorice, Maurizio Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome |
title | Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome |
title_full | Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome |
title_fullStr | Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome |
title_full_unstemmed | Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome |
title_short | Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome |
title_sort | relationship between gender differences and clinical outcome in patients with the antiphospholipid syndrome |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289158/ https://www.ncbi.nlm.nih.gov/pubmed/35860235 http://dx.doi.org/10.3389/fimmu.2022.932181 |
work_keys_str_mv | AT trugliasimona relationshipbetweengenderdifferencesandclinicaloutcomeinpatientswiththeantiphospholipidsyndrome AT capozziantonella relationshipbetweengenderdifferencesandclinicaloutcomeinpatientswiththeantiphospholipidsyndrome AT mancusosilvia relationshipbetweengenderdifferencesandclinicaloutcomeinpatientswiththeantiphospholipidsyndrome AT manganellivaleria relationshipbetweengenderdifferencesandclinicaloutcomeinpatientswiththeantiphospholipidsyndrome AT rapinoluca relationshipbetweengenderdifferencesandclinicaloutcomeinpatientswiththeantiphospholipidsyndrome AT riitanogloria relationshipbetweengenderdifferencesandclinicaloutcomeinpatientswiththeantiphospholipidsyndrome AT recalchiserena relationshipbetweengenderdifferencesandclinicaloutcomeinpatientswiththeantiphospholipidsyndrome AT colafrancescoserena relationshipbetweengenderdifferencesandclinicaloutcomeinpatientswiththeantiphospholipidsyndrome AT ceccarellifulvia relationshipbetweengenderdifferencesandclinicaloutcomeinpatientswiththeantiphospholipidsyndrome AT garofalotina relationshipbetweengenderdifferencesandclinicaloutcomeinpatientswiththeantiphospholipidsyndrome AT alessandricristiano relationshipbetweengenderdifferencesandclinicaloutcomeinpatientswiththeantiphospholipidsyndrome AT longoagostina relationshipbetweengenderdifferencesandclinicaloutcomeinpatientswiththeantiphospholipidsyndrome AT misasiroberta relationshipbetweengenderdifferencesandclinicaloutcomeinpatientswiththeantiphospholipidsyndrome AT contifabrizio relationshipbetweengenderdifferencesandclinicaloutcomeinpatientswiththeantiphospholipidsyndrome AT soricemaurizio relationshipbetweengenderdifferencesandclinicaloutcomeinpatientswiththeantiphospholipidsyndrome |